These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18540533)

  • 1. The future of cancer vaccines for non-small-cell lung cancer: ongoing trials.
    Choudhury A; Palma M; Mellstedt H
    Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S37-44. PubMed ID: 18540533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccines explored in patients with non-small cell lung cancer.
    Ma K; Tang YH
    Anticancer Agents Med Chem; 2014 Feb; 14(2):256-64. PubMed ID: 24237217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
    Rossi A
    Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
    [No Abstract]   [Full Text] [Related]  

  • 4. Current state of vaccine therapies in non-small-cell lung cancer.
    Romero P
    Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S28-36. PubMed ID: 18540532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine immunotherapy in lung cancer: Clinical experience and future directions.
    Freeman-Keller M; Goldman J; Gray J
    Pharmacol Ther; 2015 Sep; 153():1-9. PubMed ID: 25989231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.
    Limacher JM; Spring-Giusti C; Bellon N; Ancian P; Rooke R; Bonnefoy JY
    Expert Rev Vaccines; 2013 Mar; 12(3):263-70. PubMed ID: 23496666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor vaccine in non-small-cell lung cancer.
    Gonzalez Marinello GM; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2012 Apr; 12(4):439-45. PubMed ID: 22500681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
    De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development.
    Decoster L; Wauters I; Vansteenkiste JF
    Ann Oncol; 2012 Jun; 23(6):1387-93. PubMed ID: 22156658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
    Perez CA; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and immunotherapy for non-small cell lung cancer.
    Morgensztern D; Goodgame B; Govindan R
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S463-5. PubMed ID: 21102240
    [No Abstract]   [Full Text] [Related]  

  • 12. Early clinical trial experience with vaccine therapies in non-small-cell lung cancer.
    Ho C; Ochsenbein AF; Gautschi O; Davies AM
    Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S20-7. PubMed ID: 18540531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine.
    Tagliamento M; Rijavec E; Barletta G; Biello F; Rossi G; Grossi F; Genova C
    Expert Opin Biol Ther; 2018 Jul; 18(7):829-835. PubMed ID: 29936901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
    Raez LE; Santos ES; Mudad R; Podack ER
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of the art in non-small cell lung cancer immunotherapy.
    Seetharamu N
    Semin Thorac Cardiovasc Surg; 2014; 26(1):26-35. PubMed ID: 24952755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
    Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
    Hall RD; Gray JE; Chiappori AA
    Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer immunotherapy.
    Raez LE; Fein S; Podack ER
    Clin Med Res; 2005 Nov; 3(4):221-8. PubMed ID: 16303887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience.
    Mellstedt H; Vansteenkiste J; Thatcher N
    Lung Cancer; 2011 Jul; 73(1):11-7. PubMed ID: 21474197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer vaccine demonstrates enhanced antitumor immunity.
    Oncology (Williston Park); 2001 Jan; 15(1):36, 83. PubMed ID: 11271980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.